LincRNA-p21:乙醇诱导的肝损伤及其纳米粒子溶液中的双刃剑
Shun Wang1, Zhao-Chao Nie1, Yang Liu2
1Department of Clinical Laboratory, The Second Qilu Hospital of Shandong University, Jinan, Shandong, 250033, People's Republic of China.
International journal of nanomedicine
|February 20, 2026
概括
长跨基因非编码RNA-p21在与酒精有关的肝病 (ALD) 中具有双重作用,在急性损伤中促进自,但通过铁死症加剧慢性损伤. 一个新的纳米平台显示了ALD的治疗潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
背景情况:
- 与酒精有关的肝病 (ALD) 是一个主要的全球健康问题,推动了对新型治疗点的需求.
- 长跨基因非编码RNA (lincRNA) -p21正在研究其在肝损伤中的作用以及作为治疗策略的潜力.
研究的目的:
- 为了研究lincRNA-p21在酒精诱导的肝损伤中的功能.
- 探索针对ALD中的lincRNA-p21和ferroptosis的治疗策略.
主要方法:
- 在乙醇诱导的肝损伤中 lncRNAs 的生物信息分析.
- 在体内和体外实验评估lincRNA-p21在自和铁亡中的作用.
- 研究ALKBH5.5对lincRNA-p21的m6A修饰的研究.
- 开发一种纳米平台,用于联合输送lincRNA-p21和铁灭抑制剂.
主要成果:
- LincRNA-p21促进了自,防止了乙醇诱导的急性肝损伤.
- LincRNA-p21通过增加铁亡来加剧慢性乙醇诱导的肝损伤.
- ALKBH5调解了m6A脱甲基化和lincRNA-p21.21的上调.
- 在ALD模型中,ferr-1/lincRNA-p21@NP纳米系统证明了治疗功效.
结论:
- LincRNA-p21在ALD中表现出双重作用,影响自和铁亡.
- 开发的纳米平台为与酒精有关的肝病提供了一个有前途的治疗方法.
相关概念视频
Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...


